News - Page 121 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Numinus Wellness Inc. Graduates to the OTCQX Best Market

Numinus Wellness Inc. Graduates to the OTCQX Best Market

Post published:January 26, 2022
Post category:Press Release

Read more about the article MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2022

MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2022

Post published:January 25, 2022
Post category:Press Release

Read more about the article Mindset Pharma Enters Manufacturing Agreement with Leading CDMO to Produce Pharmaceutical Grade Batches of Next-Generation Psilocybin Drug Candidate, MSP-1014

Mindset Pharma Enters Manufacturing Agreement with Leading CDMO to Produce Pharmaceutical Grade Batches of Next-Generation Psilocybin Drug Candidate, MSP-1014

Post published:January 25, 2022
Post category:Press Release

Read more about the article FDA Clears MindMed IND for MM-120 in Treatment of Generalized Anxiety Disorder

FDA Clears MindMed IND for MM-120 in Treatment of Generalized Anxiety Disorder

Post published:January 25, 2022
Post category:Press Release

Read more about the article Mydecine Partners with Combat Stress to Treat Post-Traumatic Stress Disorder in Veterans

Mydecine Partners with Combat Stress to Treat Post-Traumatic Stress Disorder in Veterans

Post published:January 24, 2022
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Discloses Novel Salt Patent Strategy as Part of its Psychedelic Drug DMT Intellectual Property

Algernon Pharmaceuticals Discloses Novel Salt Patent Strategy as Part of its Psychedelic Drug DMT Intellectual Property

Post published:January 24, 2022
Post category:Press Release

Read more about the article Beckley Psytech Announces First Cohort of Psychotherapists Have Begun Training for Treatment Resistant Depression Phase 2 Trials

Beckley Psytech Announces First Cohort of Psychotherapists Have Begun Training for Treatment Resistant Depression Phase 2 Trials

Post published:January 24, 2022
Post category:Press Release

Read more about the article Psychedelic Bulletin: DEA Moves to Schedule 5 Tryptamines; Eleusis Unveils SPAC; COMPASS Seeks LSD Patents

Psychedelic Bulletin: DEA Moves to Schedule 5 Tryptamines; Eleusis Unveils SPAC; COMPASS Seeks LSD Patents

Post published:January 22, 2022
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Company Highlights in 2021

Psychedelic Company Highlights in 2021

Post published:January 20, 2022
Post category:Analysis

Numinus Wellness Inc. Reports Q1 2022 Results

Post published:January 20, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.